Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

Dennis Shung, MD, on Machine-Learning Risk Score for Upper GI Bleeding
Podcasts
Dennis Shung, MD, on Machine-Learning Risk Score for Upper GI Bleeding
05/28/2020
He talks about his latest research paper in which his team used machine learning to develop a risk-stratification model to predict which patients would experience upper gastrointestinal bleeding and then compared the model’s performance with...
He talks about his latest research paper in which his team used machine learning to develop a risk-stratification model to predict which patients would experience upper gastrointestinal bleeding and then compared the model’s performance with...
He talks about his latest...
05/28/2020
Gastroenterology
Mark Pimentel, MD, on the ACG's SIBO Guidelines
Podcasts
Mark Pimentel, MD, on the ACG's SIBO Guidelines
04/22/2020
He talks about the American College of Gastroenterology's new clinical guideline on small intestinal bacterial overgrowth (SIBO), how the guideline attempts to clear up the controversies around diagnosis and treatment of SIBO, and more.
He talks about the American College of Gastroenterology's new clinical guideline on small intestinal bacterial overgrowth (SIBO), how the guideline attempts to clear up the controversies around diagnosis and treatment of SIBO, and more.
He talks about the American...
04/22/2020
Gastroenterology

Advertisement

Veronique Morinville, MDCM, on EUS and ERCP for Evaluating and Treating Children With Chronic Pancreatitis
Podcasts
Veronique Morinville, MDCM, on EUS and ERCP for Evaluating and Treating Children With Chronic Pancreatitis
04/13/2020
She talks about the latest NASPGHAN position paper on roles of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the evaluation and treatment of chronic pancreatitis in children.
She talks about the latest NASPGHAN position paper on roles of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the evaluation and treatment of chronic pancreatitis in children.
She talks about the latest...
04/13/2020
Gastroenterology
Dhyanesh A. Patel, MD, on PPI Use and Risk of Adverse Effects
Podcasts
Dhyanesh A. Patel, MD, on PPI Use and Risk of Adverse Effects
01/09/2020
Dr Patel, from Vanderbilt University Medical Center, highlights the current role of proton-pump inhibitors and related adverse effects, indications for their use, and more.
Dr Patel, from Vanderbilt University Medical Center, highlights the current role of proton-pump inhibitors and related adverse effects, indications for their use, and more.
Dr Patel, from Vanderbilt...
01/09/2020
Gastroenterology
Mark Pimentel, MD, on the 'Promising' Future of IBS Management
Podcasts
Mark Pimentel, MD, on the 'Promising' Future of IBS Management
01/06/2020
Dr Pimentel, from Cedars-Sinai, discusses the current challenges of IBS management, how food poisoning and a low fermentation diet impact the disease, promising strategies for the future, and more.
Dr Pimentel, from Cedars-Sinai, discusses the current challenges of IBS management, how food poisoning and a low fermentation diet impact the disease, promising strategies for the future, and more.
Dr Pimentel, from Cedars-Sinai,...
01/06/2020
Gastroenterology

Advertisement

Podcasts
James Franciosi, MD, MS, MSCE, on How Genetic Variations Influence PPI Therapy in Pediatric EoE
12/20/2019
Dr Franciosi, from Nemours Children’s Hospital, discusses the prevalence of pediatric eosinophilic esophagitis (EoE), his research on how genetic variations can differentiate responses to proton-pump inhibitor therapy in pediatric EoE, and...
Dr Franciosi, from Nemours Children’s Hospital, discusses the prevalence of pediatric eosinophilic esophagitis (EoE), his research on how genetic variations can differentiate responses to proton-pump inhibitor therapy in pediatric EoE, and...
Dr Franciosi, from Nemours...
12/20/2019
Gastroenterology
Podcasts
Alan Bonder, MD, on New Therapeutic Options for the Treatment of Primary Biliary Cholangitis
12/18/2019
In this podcast, Dr Bonder, from Beth Israel Deaconess Medical Center, discusses the newest therapeutic options available for the treatment of primary biliary cholangitis, how a gastroenterologist can approach management challenges, and more.
In this podcast, Dr Bonder, from Beth Israel Deaconess Medical Center, discusses the newest therapeutic options available for the treatment of primary biliary cholangitis, how a gastroenterologist can approach management challenges, and more.
In this podcast, Dr Bonder,...
12/18/2019
Gastroenterology
Podcasts
Elizabeth B. Rand, MD, on Managing Autoimmune Hepatitis in Children
12/03/2019
Dr Rand, from Children's Hospital of Philadelphia, highlights current diagnosis and management strategies for pediatric autoimmune hepatitis, whether steroids are necessary for every patient, and more.
Dr Rand, from Children's Hospital of Philadelphia, highlights current diagnosis and management strategies for pediatric autoimmune hepatitis, whether steroids are necessary for every patient, and more.
Dr Rand, from Children's...
12/03/2019
Gastroenterology

Advertisement

Podcasts
Stephen Harrison, MD, on Key Takeaways for Management of NAFLD and NASH
11/21/2019
Dr Harrison discusses key takeaways for gastroenterologists and hepatologists about the management of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Dr Harrison discusses key takeaways for gastroenterologists and hepatologists about the management of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Dr Harrison discusses key...
11/21/2019
Gastroenterology
Podcasts
Tiffany Taft, PsyD, on Internalized Stigma in Eosinophilic GI Disorders
11/19/2019
She discusses her study that evaluated internalized stigma in adults with eosinophilic gastrointestinal disorders, evidence-based psychological interventions that are beneficial in reducing this stigma, and more.
She discusses her study that evaluated internalized stigma in adults with eosinophilic gastrointestinal disorders, evidence-based psychological interventions that are beneficial in reducing this stigma, and more.
She discusses her study that...
11/19/2019
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Colonoscopy After Diverticulitis Usually Unnecessary
11/14/2024
In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.
In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.
In colonoscopies performed...
11/14/2024
Gastroenterology
News
Upper Gl Mucosal Damage Associated With Parkinson's Disease
10/18/2024
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI)...
10/18/2024
Gastroenterology
News
Vonoprozan Compared to PPIs for Peptic Ulcer Rebleeding Prevention
10/18/2024
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective...
10/18/2024
Gastroenterology
News
NAFLD or MASLD? Research Looks at Concordance of Criteria
10/18/2024
New nomenclature shows strong applicability in real-world clinical settings.
New nomenclature shows strong applicability in real-world clinical settings.
New nomenclature shows strong...
10/18/2024
Gastroenterology
News
Liver Histology Impact on Long-Term Clinical Outcomes in MASH
10/18/2024
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower...
10/18/2024
Gastroenterology
News
AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD
10/18/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of...
10/18/2024
Gastroenterology
News
New Age Recommendation Yields Uptake in CRC Screening But Disparities Found
10/18/2024
Income level and location drove variations in rates of increase, authors of a retrospective cohort study found.
Income level and location drove variations in rates of increase, authors of a retrospective cohort study found.
Income level and location drove...
10/18/2024
Gastroenterology
News
Repeat FIT Offers Greater Differentiation of Patients With, Without Significant Pathology
10/09/2024
Conducting repeat fecal immunochemical tests doubled the detection rates of colorectal cancer and significant bowel disease, researchers reported.
Conducting repeat fecal immunochemical tests doubled the detection rates of colorectal cancer and significant bowel disease, researchers reported.
Conducting repeat fecal...
10/09/2024
Gastroenterology
News
AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD
10/08/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of...
10/08/2024
Gastroenterology
News
FDA Approves Cologuard Plus
10/07/2024
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug...
10/07/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use